ReviewCurrent oncology (Toronto, Ont.)2023

Developments in Checkpoint Inhibitor Therapy for the Management of Deficient Mismatch Repair (dMMR) Rectal Cancer.

Alan Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.